We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FORTY:NASDAQFormula Systems (1985) Ltd. Analysis

Data as of 2026-04-04 - not real-time

$124.83

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Formula Systems (1985) Ltd. (FORTY) is trading at $124.83, well below its 20‑day SMA of $125.54 and its 50‑day SMA of $131.58, indicating a short‑term bearish bias. The MACD line sits just under the signal line with a near‑zero histogram, reinforcing the bearish momentum, while the RSI of 48.9 suggests the stock is neither overbought nor oversold. Volatility is extremely high at 62.9% over the past 30 days, and the beta of 0.27 points to low market correlation, meaning price swings are driven more by company‑specific factors than broader market moves. Recent press releases highlight an 18.4% revenue jump to $2.63 bn and net income of $606.5 m for FY 2025, yet the forward earnings outlook remains undefined and the PE ratio of 54.3 far exceeds the industry average of 33.5, signaling potential overvaluation. The dividend yield of 1.97% is modest, but a payout ratio above 100% raises concerns about sustainability. Liquidity is a notable weakness – average daily volume hovers around 600 shares while the current day’s volume is only 93, implying price impact risk on any sizable trade. Overall, the stock faces a confluence of bearish technical signals, elevated volatility, and valuation pressure despite solid recent earnings growth.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below short‑term SMAs
  • High 30‑day volatility
  • Weak liquidity and low trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong FY 2025 earnings growth
  • Elevated PE relative to peers
  • Dividend payout ratio above 100% suggests possible cut

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Niche insurance‑software platform with recurring revenue
  • Overvaluation and modest revenue growth
  • Low beta but persistent high volatility

Key Metrics & Analysis

Financial Health

Revenue Growth2.40%
Profit Margin23.09%
P/E Ratio54.3
ROE6.88%
ROA3.71%
Debt/Equity32.93
P/B Ratio1.4
Industry P/E33.5

Technical Analysis

TrendBearish
RSI48.9
Support$110.28
Resistance$134.88
MA 20$125.54
MA 50$131.58
MA 200$140.36
MACDBearish
VolumeIncreasing
Fear & Greed Index78.8

Valuation

GradeOvervalued
TypeBlend
Dividend Yield1.97%

Risk Assessment

Beta0.27
Volatility62.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.